Logo
x

Search

Subscribe Now

Scilex

Scilex Relaunch Elyxyb (celecoxib oral solution) in the US for Migraine Treatment

Scilex Relaunch Elyxyb (celecoxib oral solution) in the US for Migraine Treatment

  • February 28, 2023
Scilex Acquires Rights for Elyxyb to Treat Migraine in the US and Canada

Scilex Acquires Rights for Elyxyb to Treat Migraine in the US and Canada

  • February 13, 2023
Axsome Reports Results of AXS-05 in the P-II (ASCEND) Study for the Treatment of Major Depressive Disorder

Axsome Reports Results of AXS-05 in the P-II (ASCEND) Study for the Treatment of Major Depressive Disorder

  • May 19, 2022
Scilex Reports the Initiation of SP-103 in P-II Study for the Treatment of Acute Low Back Pain

Scilex Reports the Initiation of SP-103 in P-II Study for the Treatment of Acute Low Back Pain

  • May 19, 2022
Scilex Presents Results of Semdexa (SP-102) in P-III (SEMDEXA) Trial for the Treatment of Sciatica Pain Management at ASIPP 2022

Scilex Presents Results of Semdexa (SP-102) in P-III (SEMDEXA) Trial for the Treatment of Sciatica Pain Management at ASIPP 2022

  • May 6, 2022
Scilex Reports Efficacy and Safety Results of Semdexa (SP-102) P-III (C.L.E.A.R.) Program for Sciatica Pain Management

Scilex Reports Efficacy and Safety Results of Semdexa (SP-102) P-III (C.L.E.A.R.) Program for Sciatica Pain Management

  • March 21, 2022
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.